These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15638092)

  • 1. Results of the application of intraoperative mitomycin C in dacryocystorhinostomy.
    Roozitalab MH; Amirahmadi M; Namazi MR
    Eur J Ophthalmol; 2004; 14(6):461-3. PubMed ID: 15638092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy in different age groups.
    Kar T; Yildirim Y; Topal T; Çolakoğlu K; Ünal MH
    Eur J Ophthalmol; 2016; 26(1):1-5. PubMed ID: 26044377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetabolites as an adjunct to dacryocystorhinostomy for nasolacrimal duct obstruction.
    Phelps PO; Abariga SA; Cowling BJ; Selva D; Marcet MM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012309. PubMed ID: 32259290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C in revision endoscopic dacryocystorhinostomy: a prospective randomized study.
    Penttilä E; Smirnov G; Seppä J; Kaarniranta K; Tuomilehto H
    Am J Rhinol Allergy; 2011; 25(6):425-8. PubMed ID: 22185749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic dacryocystorhinostomy not using canalicular silicone intubation tube with and without mitomycin C: a comparative study.
    Özkiris M; Özkiris A
    Eur J Ophthalmol; 2012; 22(3):320-5. PubMed ID: 21948027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indian Survey on Practice Patterns of Lacrimal and Eyelid Disorders (iSUPPLE) Report 2: Mitomycin-C and Lacrimal Stents in Dacryocystorhinostomy.
    Nair AG; Kamal S; Agarwal A
    J Craniofac Surg; 2016 Nov; 27(8):2015-2019. PubMed ID: 28005745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: A prospective, double-masked, randomized, controlled trial.
    Ari S; Gun R; Surmeli S; Atay AE; Caca I
    Curr Ther Res Clin Exp; 2009 Aug; 70(4):267-73. PubMed ID: 24683236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C.
    Feng YF; Yu JG; Shi JL; Huang JH; Sun YL; Zhao YE
    Ophthalmic Epidemiol; 2012 Dec; 19(6):364-70. PubMed ID: 23171205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis.
    Cheng SM; Feng YF; Xu L; Li Y; Huang JH
    PLoS One; 2013; 8(5):e62737. PubMed ID: 23675423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumostial injection of mitomycin C (COS-MMC) in external and endoscopic dacryocystorhinostomy: efficacy, safety profile, and outcomes.
    Kamal S; Ali MJ; Naik MN
    Ophthalmic Plast Reconstr Surg; 2014; 30(2):187-90. PubMed ID: 24614551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults.
    Dolmetsch AM
    Ophthalmology; 2010 May; 117(5):1037-40. PubMed ID: 20079535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative mitomycin C in dacryocystorhinostomy.
    You YA; Fang CT
    Ophthalmic Plast Reconstr Surg; 2001 Mar; 17(2):115-9. PubMed ID: 11281583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Conventional External Dacryocystorhinostomy with and without Mitomycin C: Experience from Eastern Nepal.
    Khadka S; Joshi P; Basnet PS; Pradhan C
    Nepal J Ophthalmol; 2020 Jul; 12(24):209-215. PubMed ID: 33978615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mitomycin C on revision endoscopic dacryocystorhinostomy.
    Ozkiriş M; Ozkiriş A; Göktaş S
    J Craniofac Surg; 2012 Nov; 23(6):e608-10. PubMed ID: 23172494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silicone nasolacrimal intubation with mitomycin-C: a prospective, randomized, double-masked study.
    Liu D; Bosley TM
    Ophthalmology; 2003 Feb; 110(2):306-10. PubMed ID: 12578771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy.
    Ozsutcu M; Balci O; Tanriverdi C; Demirci G
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):873-877. PubMed ID: 27664138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mitomycin C on success rate in dacryocystorhinostomy with silicone tube intubation and improper flaps.
    Eshraghy B; Raygan F; Tabatabaie SZ; Tari AS; Kasaee A; Rajabi MT
    Eur J Ophthalmol; 2012; 22(3):326-9. PubMed ID: 21725935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the adjunctive use of mitomycin C in primary and revision, external and endonasal dacryocystorhinostomy.
    Xue K; Mellington FE; Norris JH
    Orbit; 2014 Aug; 33(4):239-44. PubMed ID: 24410627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of intraoperative mitomycin C application in dacryocystorhinostomy.
    Liao SL; Kao SC; Tseng JH; Chen MS; Hou PK
    Br J Ophthalmol; 2000 Aug; 84(8):903-6. PubMed ID: 10906101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial.
    Ragab SM; Elsherif HS; Shehata EM; Younes A; Gamea AM
    Otolaryngol Head Neck Surg; 2012 Nov; 147(5):937-42. PubMed ID: 22645114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.